NANTHEALTH INC - NOTE 5.500%12/1

CUSIP: 630104AB3

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Debt / NOTE 5.500%12/1
Market price (% of par)
98.22%
Total 13F principal
$54,772,240
Principal change
-$12,227,760
Total reported market value
$65,571,563
Number of holders
5
Value change
-$11,763,239,962
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 630104AB3?
CUSIP 630104AB3 identifies 630104AB3 - NANTHEALTH INC - NOTE 5.500%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NANTHEALTH INC - NOTE 5.500%12/1 as of Q1 2021

As of 31 Mar 2021, NANTHEALTH INC - NOTE 5.500%12/1 was held by 5 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $54,772,240 in principal (par value) of the bond. The largest 5 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, DG Capital Management, LLC, Jefferies Group LLC, Laurion Capital Management LP, and Context Capital Management, LLC. This page lists 5 institutional bondholders reporting positions for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.